1. Volume 118, Issue 4, Pages 661-669 (April 2000)
Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa 
Elly C. Klinkenberg-Knol, Frits Nelis, John Dent, Pleun Snel, Brent Mitchell, Peter Prichard, David Lloyd, Niilo Havu, Madeline H. Frame, Jonas Romàn, Anders Walan 
Gastroenterology 
Volume 118, Issue 4, Pages (April 2000)
DOI: /S (00)
Copyright © 2000 American Gastroenterological Association Terms and Conditions

2. Fig. 1
Number of patients (▩) and number of relapses (■) during each year of the study.
Gastroenterology  , DOI: ( /S (00) )
Copyright © 2000 American Gastroenterological Association Terms and Conditions

3. Fig. 2
Proportion of H. pylori–positive (top panels) and H. pylori–negative (lower panels) patients with (A) inflammation, (B) activity, and (C) atrophy of the corpus mucosa at first and last visit. □, None; ▩, mild; ●, moderate; ■, severe.
Gastroenterology  , DOI: ( /S (00) )
Copyright © 2000 American Gastroenterological Association Terms and Conditions

4. Fig. 2
Proportion of H. pylori–positive (top panels) and H. pylori–negative (lower panels) patients with (A) inflammation, (B) activity, and (C) atrophy of the corpus mucosa at first and last visit. □, None; ▩, mild; ●, moderate; ■, severe.
Gastroenterology  , DOI: ( /S (00) )
Copyright © 2000 American Gastroenterological Association Terms and Conditions

5. Fig. 2
Proportion of H. pylori–positive (top panels) and H. pylori–negative (lower panels) patients with (A) inflammation, (B) activity, and (C) atrophy of the corpus mucosa at first and last visit. □, None; ▩, mild; ●, moderate; ■, severe.
Gastroenterology  , DOI: ( /S (00) )
Copyright © 2000 American Gastroenterological Association Terms and Conditions

6. Fig. 2
Proportion of H. pylori–positive (top panels) and H. pylori–negative (lower panels) patients with (A) inflammation, (B) activity, and (C) atrophy of the corpus mucosa at first and last visit. □, None; ▩, mild; ●, moderate; ■, severe.
Gastroenterology  , DOI: ( /S (00) )
Copyright © 2000 American Gastroenterological Association Terms and Conditions

7. Fig. 2
Proportion of H. pylori–positive (top panels) and H. pylori–negative (lower panels) patients with (A) inflammation, (B) activity, and (C) atrophy of the corpus mucosa at first and last visit. □, None; ▩, mild; ●, moderate; ■, severe.
Gastroenterology  , DOI: ( /S (00) )
Copyright © 2000 American Gastroenterological Association Terms and Conditions

8. Fig. 2
Proportion of H. pylori–positive (top panels) and H. pylori–negative (lower panels) patients with (A) inflammation, (B) activity, and (C) atrophy of the corpus mucosa at first and last visit. □, None; ▩, mild; ●, moderate; ■, severe.
Gastroenterology  , DOI: ( /S (00) )
Copyright © 2000 American Gastroenterological Association Terms and Conditions

9. Fig. 3
Proportion of (A) H. pylori–positive and (B) H. pylori–negative patients with diffuse (▩), linear (●), micronodular (■), and no (□) argyrophil cell hyperplasia at first and last visit.
Gastroenterology  , DOI: ( /S (00) )
Copyright © 2000 American Gastroenterological Association Terms and Conditions

10. Fig. 3
Proportion of (A) H. pylori–positive and (B) H. pylori–negative patients with diffuse (▩), linear (●), micronodular (■), and no (□) argyrophil cell hyperplasia at first and last visit.
Gastroenterology  , DOI: ( /S (00) )
Copyright © 2000 American Gastroenterological Association Terms and Conditions